Meeting
2013 Genitourinary Cancers Symposium
A multi-analyte assay for the noninvasive detection of bladder cancer.
Authors
Makito Miyake
MD Anderson Cancer Center Orlando, Orlando, FL
Makito Miyake , Steve Goodison , Myron Chang , Yunfeng Dai , Virginia Urquidi , Charles Joel Rosser
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Prostate, Penile, Urethral, and Testicular Cancer, and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancer
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 31, 2013 (suppl 6; abstr 306)
DOI
10.1200/jco.2013.31.6_suppl.306
Abstract #
306
Poster Bd #
H17
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
EphA2 on urinary extracellular vesicles as a novel diagnostic marker for bladder cancer and its effect on the invasiveness of bladder cancer.
First Author: Eisuke Tomiyama
Poster
2023 ASCO Genitourinary Cancers Symposium
Survey of keratin 17 (K17) expression in different urothelial malignancies.
First Author: Thorsten Ecke
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Analysis of tumor-associated macrophages' heterogeneity in colorectal cancer patients using single-cell RNA-seq data.
First Author: Yulia Innokenteva Nussbaum
Poster
2020 ASCO Virtual Scientific Program
Serum biomarkers of inflammation (ferritin, IL-8, TNFR1) and outcomes in BOLERO-2, a phase III trial of HR+/HER2- metastatic breast cancer treated with everolimus (mTOR inhibitor).
First Author: Suhail M. Ali